1. Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression. Palmer TD, Martínez CH, Vasquez C, Hebron KE, Jones-Paris C, Arnold SA, Chan SM, Chalasani V, Gomez-Lemus JA, Williams AK, Chin JL, Giannico GA, Ketova T, Lewis JD, Zijlstra A (2014) Cancer Res 74(1): 173-87
    › Primary publication · 24220242 (PubMed) · PMC3947299 (PubMed Central)
  2. Flipping the switch: integrin switching provides metastatic competence. Madamanchi A, Zijlstra A, Zutter MM (2014) Sci Signal 7(318): pe9
    › Primary publication · 24667375 (PubMed) · PMC4209128 (PubMed Central)
  3. ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone. Hansen AG, Arnold SA, Jiang M, Palmer TD, Ketova T, Merkel A, Pickup M, Samaras S, Shyr Y, Moses HL, Hayward SW, Sterling JA, Zijlstra A (2014) Cancer Res 74(5): 1404-15
    › Primary publication · 24385212 (PubMed) · PMC4149913 (PubMed Central)
  4. Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome. Hansen AG, Freeman TJ, Arnold SA, Starchenko A, Jones-Paris CR, Gilger MA, Washington MK, Fan KH, Shyr Y, Beauchamp RD, Zijlstra A (2013) Cancer Res 73(10): 2955-64
    › Primary publication · 23539446 (PubMed) · PMC3660148 (PubMed Central)
  5. Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. Campbell JP, Karolak MR, Ma Y, Perrien DS, Masood-Campbell SK, Penner NL, Munoz SA, Zijlstra A, Yang X, Sterling JA, Elefteriou F (2012) PLoS Biol 10(7): e1001363
    › Primary publication · 22815651 (PubMed) · PMC3398959 (PubMed Central)
  6. Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery. Pink DB, Schulte W, Parseghian MH, Zijlstra A, Lewis JD (2012) PLoS One 7(3): e33760
    › Primary publication · 22479438 (PubMed) · PMC3315578 (PubMed Central)
  7. Magnetically attachable stencils and the non-destructive analysis of the contribution made by the underlying matrix to cell migration. Ashby WJ, Wikswo JP, Zijlstra A (2012) Biomaterials 33(33): 8189-203
    › Primary publication · 22940214 (PubMed) · PMC3444626 (PubMed Central)
  8. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. Matise LA, Palmer TD, Ashby WJ, Nashabi A, Chytil A, Aakre M, Pickup MW, Gorska AE, Zijlstra A, Moses HL (2012) Breast Cancer Res 14(4): R98
    › Primary publication · 22748014 (PubMed) · PMC3680921 (PubMed Central)
  9. Established and novel methods of interrogating two-dimensional cell migration. Ashby WJ, Zijlstra A (2012) Integr Biol (Camb) 4(11): 1338-50
    › Primary publication · 23038152 (PubMed) · PMC4165521 (PubMed Central)
  10. The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer. Ramirez NE, Zhang Z, Madamanchi A, Boyd KL, O'Rear LD, Nashabi A, Li Z, Dupont WD, Zijlstra A, Zutter MM (2011) J Clin Invest 121(1): 226-37
    › Primary publication · 21135504 (PubMed) · PMC3007139 (PubMed Central)